TMPRSS2-ERG gene fusion in metastatic prostate cancers: A study of fine needle aspiration specimens

Chinese Journal of Pathology

Volumn 40, Issue 6, 2011, Pages 392-396

  Xiao, Li ^a   Zhu, Xiong Zeng ^a   Wang, Yan ^a   Gong, Yun ^a   Guo, C Charles ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; CHROMOGRANIN A; ONCOPROTEIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN TYROSINE PHOSPHATASE; SYNAPTOPHYSIN; TMPRSS2 ERG FUSION PROTEIN, HUMAN; TMPRSS2-ERG FUSION PROTEIN, HUMAN;

ADENOCARCINOMA; AGED; ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE FUSION; GENE REARRANGEMENT; GENETICS; HUMAN; LIVER TUMOR; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PROSTATE TUMOR; SMALL CELL CARCINOMA;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CARCINOMA, SMALL CELL; CHROMOGRANIN A; FOLLOW-UP STUDIES; GENE FUSION; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; ONCOGENE PROTEINS, FUSION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN TYROSINE PHOSPHATASES; SYNAPTOPHYSIN;

EID: 79960487091     PISSN: 05295807     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0529-5807.2011.06.008     Document Type: Article

References (20)

1. Petrovics G, Liu A, Shaheduzzaman S, et al. Frequent overexpression of ETS-relaled gene-1 (ERG1) in prostate cancer transcriptome. Oncogene,2005,24(23) :3847-3852. (Pubitemid 40826884)
2. Tomlins SA, Rhodes DR, Pemer S, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science,2005,310(5748):644- 648. (Pubitemid 41528150)
3. Winnes M, Lissbrant E, Damber JE, et al. Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer. Oncol Rep,2007, 17(5) : 1033-1036.
4. Nam RK, Sugar L, WangZ.etal. Expression of TMPRSS2:ERG gene fusion in prostate cancer cells is an important prognostic factor for cancer progression. Cancer Biol Ther,2007,6(1) : 40-45. (Pubitemid 46294173)
5. Saramki OR, Harjula AE, Martikainen PM,et al. TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis. Clin Cancer Res,2008,14(11) :3395-3400.
6. Gopalan A, Leversha MA, Satagopan JM,et al. TMPRSS2-ERG gene fusion is not associated with outcome in patients treated by prostatectomy. Cancer Res,2009,69(4): 1400-1406.
7. Darnel AD, Lafargue CJ, Vollmer RT, et al. TMPRSS2-ERG fusion is frequently observed in Gleason pattern 3 prostate cancer in a Canadian cohort. Cancer Biol Ther,2009,8(2): 125-130.
8. PeraerS, Demichelis F, Beroukhim R,et al. TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res,2006,66(17) :8337-8341. (Pubitemid 44449140)
9. Rajput AB, Miller MA, De Luca A,et al. Frequency of the TMPRSS2: ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. J Clin Pathol,2007,60(11) :1238-1243. (Pubitemid 350084545)
10. Wang J, Cai Y, Ren C, et al. Expression of variant TMPRSS2/ ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res, 2006,66(17) :8347-8351. (Pubitemid 44449142)
11. Mehra R, Tomlins SA, Shen R, et al. Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer. Mod Pathol,2007,20(5) :538-544. (Pubitemid 46631996)
12. Attard G, Clark J, Ambroisine L,et al. Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. Oncogene,2008,27(3) :253-263.
13. FitzGerald LM, Agalliu I, Johnson K, et al. Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. BMCCancer,2008,8:230.
14. Mosquera JM, Mehra R, Regan MM, et al. Prevalence of TMPRSS2-ERG fusion prostate cancer among men undergoing prostate biopsy in the United States. Clin Cancer Res,2009,15 (14):47064711.
15. Mehra R, Tomlins SA, Yu J.et al. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. Cancer Res,2008,68(10) :3584-3590.
16. Perner S, Mosquera JM, Demichelis F, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol,2007,31(6) :882-888. (Pubitemid 47165141)
17. Yoshimoto M, Joshua AM, Cunha IW, et al. Absence of TMPRSS2: ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome. Mod Pathol, 2008,21(12): 1451-1460.
18. Epstein JI, Algaba F, Allsbrook Jr FW, et al. Acinar adenocarcinoma//Eble JN, Sauter G, Epstein JI. World Health Organization classification of tumors. Pathology and genetics, tumors of theurinary system and male genital organs. Lyon: IARC Press,2004:186-188.
19. Han B, Mehra R, Suleman K,et al. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma. Mod Pathol,2009,22(9): 1176-1185.
20. Guo CC, Dancer JY, Wang Y,et al. TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate. Hum Pathol,2011,42(1): 11-17.